Connect with us

Business Wire

Takeda and London School of Hygiene & Tropical Medicine Establish “Takeda Chair in Global Child Health”

Business Wire

Published

on

Reading Time: 4 minutes
  • The “Takeda Chair in Global Child Health” is the first Chair at
    the London School of Hygiene & Tropical Medicine (LSHTM) to be fully
    endowed by a company
  • Partnership will boost LSHTM’s innovative research into child
    health and survival that helps policymakers to make evidence-based
    decisions; the Chair’s continuous funding supports LSHTM to plan
    strategically and sustainably to improve heath worldwide
  • Demonstrates Takeda’s long-term commitment to the people and
    cutting-edge science that help bring life-changing therapies and
    vaccines to patients worldwide

OSAKA, Japan & LONDON–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK)
(“Takeda”) and the London School of Hygiene & Tropical Medicine (LSHTM)
will announce today at the evening reception, hosted by the Embassy of
Japan in the United Kingdom, the establishment of the Takeda Chair in
Global Child Health, endowed by a £3 million donation by Takeda to
LSHTM. The School’s first fully endowed corporate chair, it will support
vital research into reducing 5.3 million child deaths in low and
middle-income countries.

Takeda’s donation will enable LSHTM to recruit a world-class researcher
and educator to join its innovative academic team as the first holder of
the Takeda Chair in Global Child Health. This post will play a critical
role in consolidating LSHTM’s child health research across more than 100
countries, accelerating change for one of the biggest global health
challenges, and further strengthening LSHTM’s position as a leader in
maternal, child and adolescent health.

Christophe Weber, President and CEO of Takeda, stated, “Takeda’s aim is
to thrive at the cutting edge of innovation that helps solve unmet
medical needs, both through our own R&D and in collaboration with
exceptional partners across the globe. We believe that global health
research and the training of new global healthcare professionals are
essential to the ongoing translation of science into life-changing
therapies for patients. This Chair does both. We are excited to partner
with LSHTM, renowned for its pioneering research and uniquely placed to
realize the full potential impact of the Chair, and in doing so directly
benefitting millions of children and their families.”

Through its Corporate Social Responsibility (CSR) activities, Takeda has
supported health worker training and capacity building, immunization
campaigns, health system strengthening and maternal, child and newborn
health in the developing world for over a decade. Additionally, Takeda
has a long history of supporting child health beyond CSR. For over 70
years, the company has supplied critical vaccines to the children of
Japan, and more recently is working to expand impact on global health
beyond Japan through a pipeline with the potential to transform the
global picture for several neglected diseases.

More than five million children under the age of five die each year,
half of whom die within the neonatal period (birth to one month old),
with the next largest number being due to childhood infections such as
pneumonia and diarrhea. While the vast majority of these deaths are
preventable, key research gaps remain. The Takeda Chair in Global Child
Health will enable a ‘rising star’ to bridge research, public policy,
and healthcare delivery by developing thought leadership in child
survival and health through innovative research, including vaccines,
neonatal care, under-nutrition, and infection diagnostics and treatments.

Professor Baron Peter Piot, Director of LSHTM, stated, “We are honored
to partner with Takeda to create this Professorial Chair, the first in
our School’s history to have been fully endowed through corporate
support. This donation is incredibly valuable, providing ongoing funding
and support for a Professorial Chair in Global Child Health – a pivotal
part of our continuing mission to improve health worldwide. We are
deeply thankful to Takeda for their generosity as we work together to
transform the health of future generations.”

Professor Joy Lawn, Director of LSHTM’s MARCH Centre (Maternal
Adolescent, Reproductive & Child Health Centre), said, “The Takeda Chair
will advance the evidence base for child survival and child health
around the world, enable innovations and drive an important emphasis on
the science and realities of healthcare implementation. This Chair will
be instrumental in linking evidence to action, especially in sub-Saharan
Africa and South Asia, where the majority of child deaths occur. We are
grateful for Takeda’s generous support which will advance child health
worldwide, and aligns with the mission of the London School of Hygiene &
Tropical Medicine and our school’s MARCH Centre.”

International recruitment for the Takeda Chair in Global Child Health
will begin in May. Due to the perpetual nature of this endowment, this
role will be awarded to generations of academics, enabling the best and
brightest academic minds to have the freedom to explore innovative ways
to improve global health.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK)
is a global, values-based, R&D-driven biopharmaceutical leader
headquartered in Japan, committed to bringing Better Health and a
Brighter Future to patients by translating science into
highly-innovative medicines. Takeda focuses its R&D efforts on four
therapeutic areas: Oncology, Gastroenterology (GI), Rare Diseases and
Neuroscience. We also make targeted R&D investments in Plasma-Derived
Therapies and Vaccines. We are focusing on developing highly innovative
medicines that contribute to making a difference in people’s lives by
advancing the frontier of new treatment options and leveraging our
enhanced collaborative R&D engine and capabilities to create a robust,
modality-diverse pipeline. Our employees are committed to improving
quality of life for patients and to working with our partners in health
care in approximately 80 countries and regions.

For more information, visit https://www.takeda.com

About the London School of Hygiene & Tropical Medicine

The London School of Hygiene & Tropical Medicine is a world-leading
centre for research and postgraduate education in public and global
health, with 4,500 students and more than 3,000 staff working in over
100 countries. LSHTM is one of the highest-rated research institutions
in the UK, and among the world’s leading schools in public and global
health. Our mission is to improve health and health equity in the UK and
worldwide; working in partnership to achieve excellence in public and
global health research, education and translation of knowledge into
policy and practice. For more information, visit www.lshtm.ac.uk
and https://march.lshtm.ac.uk/

Contacts

Media Inquiries:
The Press Office at LSHTM
press@lshtm.ac.uk
+44(0)207
927 2802

Takeda Pharmaceutical Company
Kazumi Kobayashi
kazumi.kobayashi@takeda.com
+81
3 3278 2095

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.

Business Wire

GRANITE CONSTRUCTION SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Granite Construction Incorporated – GVA

Business Wire

Published

on

Reading Time: 2 minutes

NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 15, 2019 to file lead plaintiff applications in a securities class action lawsuit against Granite Construction Incorporated (NYSE: GVA), if they purchased the Company’s securities between October 26, 2018 and August 1, 2019, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

What You May Do

If you purchased securities of Granite and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-gva/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 15, 2019.

About the Lawsuit

Granite and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On August 2, 2019, pre-market, the Company disclosed disappointing 2Q2019 financial results including revenue of $789.5M and $114.2M in revenue reductions due to previously disclosed non-cash charges related to four legacy joint venture projects.

On this news, the price of Granite’s shares plummeted.

The case is Greene v. Granite Construction Incorporated, 3:19-cv-04744.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com

1-877-515-1850

Continue Reading

Business Wire

GEICO’s Schneider Elected Assistant Vice President ​

Business Wire

Published

on

Reading Time: 2 minutes

CHEVY CHASE, Md.–(BUSINESS WIRE)–#GEICO–The GEICO Board of Directors has elected Ashley Schneider​ assistant vice president in the company’s product management division at GEICO corporate headquarters in Chevy Chase, Maryland.

Schneider began her GEICO career in 2007 in the pricing & product management division. She has held several positions within the division, with pricing & product management responsibility for five of the company’s 10 regional offices: Fredericksburg, Virginia; Woodbury, New York; Buffalo, New York; Tucson, Arizona; and San Diego, California.

Most recently, Schneider has been an integral part of leading GEICO’s new product development efforts.

Schneider has a bachelor’s degree in mathematics, with a concentration in actuarial science, from Loyola College in Baltimore. She is a Fellow of the Casualty Actuarial Society.

“Ashley’s talent and experience will help her succeed in her new role,” said GEICO President and CEO Bill Roberts​. “Her efforts will contribute to GEICO’s ongoing success.”

About GEICO

GEICO (Government Employees Insurance Company), the second-largest auto insurer in the U.S., was founded in 1936 and insures more than 28 million vehicles. For more than 80 years, the company has worked to make people’s lives better by protecting policyholders against unexpected events. As GEICO has grown, it has delivered money-saving coverage and outstanding customer service to policyholders through its investment in human resources and technology. GEICO is a member of the Berkshire Hathaway family of companies.

GEICO also provides homeowners, renters, condo, flood, identity theft and term life coverages through non-affiliated insurance companies secured through the GEICO Insurance Agency, Inc. Commercial auto and personal umbrella coverages are also available.

GEICO has a national workforce of 40,000 associates. GEICO sales representatives throughout the country are licensed insurance agents in order to help guide customers through coverage decisions. To make changes, report claims, print insurance cards and/or purchase additional products, policyholders can access their insurance policy here, connect via GEICO Mobile or by phone. Sales and service is also available at GEICO Local Offices.

Visit www.geico.com for a quote or to learn more.

Contacts

GEICO Communications

gcorpcomm@geico.com

To view GEICO’s Blog: https://www.geico.com/more/

Continue Reading

Business Wire

DealerSocket CEO Sejal Pietrzak Ranks Number Seven on Top SaaS CEOs List

Business Wire

Published

on

Reading Time: 2 minutes

Annual ranking of top CEOs in SaaS places Pietrzak as the only automotive executive

DALLAS–(BUSINESS WIRE)–The Software Report has released their annual listing of the Top 50 SaaS (Software as a Service) CEOs, and DealerSocket’s President and Chief Executive Officer has come in at number seven in the ranking. Pietrzak is the only CEO from an automotive company to make the list.

The exceptional CEOs on the Top 50 list were selected based on nomination submissions from colleagues, peers, and other software industry participants. Nominees were reviewed across a number of key attributes including integrity, intellect, drive, emotional intelligence, organizational culture, and operational skill. They were most closely evaluated based on qualitative and substantive commentary provided on the CEOs character.

Ms. Pietrzak’s listing as one of the few women on the list, and the only CEO from an automotive company, speaks to her leadership and high performance as the CEO of the innovative SaaS company DealerSocket,” said J. Carlos, Editor of The Software Report. “Selection to this year’s awards list was highly competitive, and the nominations for Ms. Pietrzak set her apart from the thousands of others we received.”

The most highly regarded CEOs had a high volume of nominations showing consistency to primary characteristics comprising the individual’s effective leadership style. The Software Report was impressed with the outpouring of support, respect and admiration for these leaders. It became clear that to build a high performing organization supported by a constructive and enduring culture, the CEO needed to possess a unique set of rare skills.

I’m honored to be listed among so many well-known and deserving CEOs of great software companies,” said Pietrzak. “At DealerSocket, we believe that technology has the power to transform the automotive experience, which is why we invest in innovation and unparalleled customer service. Our ranking on the Top 50 SaaS CEOs list is a reflection of the hard work and dedication shown by the entire DealerSocket team.”

To view a list of the Top 50 CEOs in SaaS, visit www.thesoftwarereport.com/the-top-50-saas-ceos-of-2019/

About DealerSocket

DealerSocket is a leading provider of software for the automotive industry, offering a suite of seamlessly integrated products to help dealers sell and service vehicles more profitably, while improving their customers’ experience. DealerSocket’s suite of products includes advanced Customer Relationship Management (CRM), innovative Digital Retail, Marketing and Websites, robust Vehicle Inventory Management, insightful Analytics Reporting, and solutions to streamline dealer operations such as Desking, Credit Reporting, Compliance, and an independent-geared Dealer Management System (DMS) for dealers of all sizes. DealerSocket’s software has helped customers sell more than 100 million vehicles throughout its 18-year history. For more information, visit DealerSocket.com or follow us on Twitter, LinkedIn, and Facebook
.

Contacts

Patrick Mendoza

PMendoza@DealerSocket.com


469-828-6325

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Business Wire7 hours ago

GRANITE CONSTRUCTION SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Granite Construction Incorporated – GVA

Business Wire10 hours ago

GEICO’s Schneider Elected Assistant Vice President ​

Business Wire11 hours ago

DealerSocket CEO Sejal Pietrzak Ranks Number Seven on Top SaaS CEOs List

IT Industry20 hours ago

UPDATE – ChinaCache Announces Changes to the Composition of the Company’s Board of Directors

Business Wire20 hours ago

Mill Point Capital Completes Carve-Out of Pioneer Transformers

Business Wire21 hours ago

CVS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CVS Health Corporation – CVS

Business Wire21 hours ago

JOHNSON & JOHNSON INVESTIGATION UPDATE by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Johnson & Johnson – JNJ

Business Wire21 hours ago

CAPITAL ONE INVESTIGATION INITIATED by Former Louisiana Attorney General:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of Capital One Financial Corporation – COF

Business Wire21 hours ago

ANHEUSER-BUSCH 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Anheuser-Busch InBev SA/NV – BUD

Business Wire21 hours ago

EROS INTERNATIONAL 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Eros International

Follow our Tweets

Trending

Please turn AdBlock off